Stay updated on NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Sign up to get notified when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.

Latest updates to the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page
- CheckyesterdayChange DetectedA site-wide NIH notice announces website transition updates and says some content may use “Super Intelligence” in place of “Artificial Intelligence.” The study record remains inaccessible.SummaryDifference1%

- Check8 days agoChange DetectedThe site footer revision identifier changed from v3.7.1 to v3.7.2; the study page continues to display a 403 error.SummaryDifference0.2%

- Check15 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the page remains a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error, making the study record inaccessible. The prior study details have been removed and replaced with the standard error page layout.SummaryDifference16%

- Check57 days agoChange DetectedThe page now shows a new revision tag v3.6.6, indicating a platform update. No study data, eligibility criteria, or primary content were modified.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision label on the page updated from v3.6.4 to v3.6.5, signaling a new build of the page. No study details or patient-facing content are affected by this change.SummaryDifference0.1%

Stay in the know with updates to NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NOTAL-OCT V.2.5 vs Commercial OCT in AMD Patients Clinical Trial page.